Abstract
Predicting how pharmaceuticals may affect heart rhythm is a crucial step in drug development and requires a deep understanding of a compound’s action on ion channels. In vitro hERG channel current recordings are an important step in evaluating the proarrhythmic potential of small molecules and are now routinely performed using automated high-throughput patch-clamp platforms. These machines can execute traditional voltage-clamp protocols aimed at specific gating processes, but the array of protocols needed to fully characterize a current is typically too long to be applied in a single cell. Shorter high-information protocols have recently been introduced that have this capability, but they are not typically compatible with high-throughput platforms. We present a new 15 second protocol to characterize hERG (Kv11.1) kinetics, suitable for both manual and high-throughput systems. We demonstrate its use on the Nanion SyncroPatch 384PE, a 384-well automated patch-clamp platform, by applying it to Chinese hamster ovary cells stably expressing hERG1a. From these recordings, we construct 124 cell-specific variants/parameterizations of a hERG model at 25°C. A further eight independent protocols are run in each cell and are used to validate the model predictions. We then combine the experimental recordings using a hierarchical Bayesian model, which we use to quantify the uncertainty in the model parameters, and their variability from cell-to-cell; we use this model to suggest reasons for the variability. This study demonstrates a robust method to measure and quantify uncertainty and shows that it is possible and practical to use high-throughput systems to capture full hERG channel kinetics quantitatively and rapidly.
Significance
We present a method for high-throughput characterization of hERG potassium channel kinetics via fitting a mathematical model to results of over 100 single-cell patch-clamp measurements collected simultaneously on an automated voltage-clamp platform. The automated patch-clamp data are used to parameterize a mathematical ion channel model fully, opening a new era of automated and rapid development of mathematical models from quick, cheap, and reliable experiments. The method also allows ample data for independent validation of the models and enables us to study experimental variability and its origins. The method can be applied to characterize different conditions, e.g., temperatures (see Part II), mutations, or the action of pharmaceuticals, and could be adapted to study many other currents.
Introduction
The human Ether-à-go-go-Related Gene (hERG) is of great importance in cardiac electrophysiology and safety pharmacology. hERG encodes the pore-forming α subunit of the ion channel Kv11.1, which conducts the rapid delayed rectifier potassium current, IKr (1). Reduction of IKr by pharmaceutical compounds or mutations can prolong the ventricular action potential (2), can increase the QT interval on the body-surface electrocardiogram, and is associated with elevated risk of Torsade de Pointes (3). Current pharmaceutical regulatory guidelines require the evaluation of effects on the hERG channel as part of preclinical drug development (4).
High-throughput automated patch-clamp screening for ion current inhibition by pharmaceutical compounds has been widely used to inform proarrhythmic safety in early drug discovery. Inhibition data from multiple ion channels can be integrated together using a mechanistically detailed in silico electrophysiology model to predict proarrhythmic risk (5). Such a strategy, combining high-throughput in vitro and in silico approaches, is being advocated by a Food and Drug Administration-led initiative, the Comprehensive in vitro Proarrhythmia Assay (6), as a core pillar of future proarrhythmic safety assessment. High-throughput automated patch-clamp has also been used to characterize the kinetics of a large number of KCNQ1 mutants that were previously variants of unknown significance (7).
Mathematical modeling of ion channel kinetics provides a quantitative summary of our current understanding, and can serve as a powerful predictive tool. The parameters in ion current models can be biophysically and physiologically meaningful and are therefore of interest in their own right. Parameterization (or calibration) of mathematical models is a concise way to characterize ion current kinetics and can also be used to quantify variability between experiments (8). A wide range of models have been proposed to describe IKr, with varying levels of biophysical detail and numbers of parameters (see Beattie et al. (9), Appendix A)). Until we have a full and clear understanding of the underlying mechanisms, simple models that capture the most relevant characteristics with a small number of parameters may be preferred.
Voltage-clamp experiments are a common source of data for calibrating ion channel models. The first models of ionic currents were proposed by Hodgkin and Huxley (10), who used stepwise voltage protocols to isolate and measure different aspects of ionic currents (e.g., time constants and voltage-dependent steady states). Following in their footsteps, many voltage step protocols have been designed to highlight particular current kinetics. Typically, these protocols involve long sections, during which the channels are brought into a particular steady state before a brief interval, during which a current is measured and then summarized using either a peak current or by fitting an exponential curve and deriving a time constant. By design, these protocols focus on a single aspect of an ion current, so several such protocols are needed to parameterize a model fully. For the hERG channel, for example, in (11), examining voltage dependence of hERG activation lasted at least 10 min before examining deactivation, inactivation, and recovery from inactivation; hence, these protocols are typically too long for a single-cell recording. More recently, simulation experiments have shown that condensed voltage-clamp protocols can be used to provide the required information in a much shorter time (12, 13). A study by Beattie et al. (9) demonstrated in vitro that sinusoidal protocols can be used to rapidly (8 s) characterize hERG kinetics on a manual patch-clamp setup. Because of hardware limitations, some automated high-throughput systems can only perform square wave or ramp voltage-clamp protocols. Here, we extend the approach of Beattie et al. (9) to make it applicable to such automated high-throughput patch-clamp systems.
Efforts have been made to address the variability observed in measurements of the hERG channel (14). However, the variability of baseline hERG characteristics remains incompletely understood. Understanding and quantifying this variability, whether it is due to cell-to-cell variability (also known as “extrinsic variability” or “population variability”) or to observational errors/uncertainties, is crucial in establishing the credibility and applicability of model predictions (15). Quantifying the variability in hERG channel kinetics requires a large number of high-quality patch-clamp measurements and an appropriate statistical framework. The duration of a standard combination of protocols makes it difficult to use them to fully characterize the current in a single cell, so that reaching the required number of cells for a thorough statistical analysis would be a very difficult and time-consuming task.
We present a new approach to overcome this problem by using a novel protocol and a high-throughput system to rapidly record many cells’ kinetics in parallel. Using these methods, we construct 124 cell-specific parameterizations of a hERG model and validate all of our model predictions against a set of independent protocols that have not been used in training or fitting the model. To ensure the stability and reproducibility of our results within the same cells, we repeat all of our measurements twice. We employ a hierarchical Bayesian framework (a multilevel statistical modeling technique) to describe the variability of hERG channel conductance and kinetics between cells and to infer the covariance between the model parameters across different cells. This study greatly increases the utility of automated high-throughput systems and provides robust tools for the uncertainty quantification that comprise an essential component of an in silico assay.
Materials and Methods
We began our work with a synthetic data study to inform the experimental design of the voltage protocols, and applied inference techniques to assess the amount of information such protocols can provide. The motivation and rationale of our newly designed protocol are discussed in the Experimental Methods. Experiments using this new protocol were performed on the Nanion SyncroPatch 384PE platform (Nanion Technologies, Munich, Germany) with a temperature control unit. We then applied global optimization, Markov chain Monte Carlo (MCMC), and hierarchical Bayesian techniques to recover parameters for a mathematical ion current model for each individual cell, as described below.
Mathematical model
We used a recently published hERG model by Beattie et al. (9), which has a Hodgkin and Huxley-style structure. This model structure has been widely used in many studies with slight modifications: the root of the model traces back to Zeng et al. (16), in which the same model structure was used but with the inactivation gate modeled as an instantaneous steady-state response. Later, in the ten Tusscher et al. (17) model, the same model structure was used, but extra parameters were introduced to make the time constant independent of the steady state. In the model that we use, the current, IKr, is modeled with a standard Ohmic expression,
(1) |
where gKr is the maximal conductance, a is a Hodgkin and Huxley (10) activation gate, and r is an inactivation gate. V is the transmembrane voltage and EK is the reversal potential, also known as the Nernst potential. EK was not inferred but was calculated directly using
(2) |
where R is the ideal gas constant, T is the absolute temperature, F is the Faraday constant, and z is the valency of the ions (equal to 1 for K+). [K+]o and [K+]i denote the extracellular and intracellular concentrations of K+, respectively, which were determined by the experimental solutions as 4 and 110 mM, respectively. The model structure is shown in Fig. 1, where
where
Our model consists of nine positive parameters θ = {gKr, p1, ..., p8}, where the units of the parameters are {pS, s−1, V−1, s−1, V−1, ...}. All model parameters must be inferred from the experimental data.
Simulations were run using Myokit (18), with tolerance settings for the CVODE solver (19) set to abs_tol = 10−8 and rel_tol = 10−10. All codes and data are freely available at https://github.com/CardiacModelling/hERGRapidCharacterisation.
Statistical model and parameter inference
To infer model parameters from experimentally observed data under a probabilistic and Bayesian framework, we specified a statistical model to relate the mathematical model and the observed experimental data:
(3) |
We assumed that noise arises from a normal distribution . This is equivalent to writing , which allows us to formulate the likelihood of observing the data y = {yk} given parameters φ = ln(θ) as
(4) |
where z = {zk} is the model simulation of given θ. We chose the parameter transformation φ = ln(θ) to turn our positively constrained physical model parameters to be unconstrained optimization variables. Using Bayes’ theorem, we can now write an equation for the likelihood of a parameter set given the observed data (the posterior) as
(5) |
with the prior
(6) |
where represents a uniform distribution.
Here, y was assumed to be the in Eq. 3 after leak correction and E-4031 subtraction have been applied as part of the data processing. We chose a uniform prior and expected our posterior to be dominated by the observed data. The details of the choice of φmin, φmax are given in Supporting Materials and Methods, Section S6.2.2. Such a formulation extends our model parameters to {θ, σ} to fully describe both the biophysical and statistical models.
We used a two-step approach to infer the model parameters. Firstly, we used a global optimization algorithm (20) to identify the parameters. Secondly, we utilized a Monte-Carlo-based sampling scheme to obtain the posterior distribution, using a population MCMC (21) algorithm with adaptive Metropolis (22) as the base sampler. The benefits of this approach are twofold. First, using a Bayesian framework allows us to incorporate prior knowledge. Second, we construct a probability (posterior) distribution to quantify uncertainty in the parameter set due to noise in the data. All inference and sampling were done via our open-source Python package, PINTS (23).
Hierarchical Bayesian model
We combined multiple experimental recordings using a multilevel modeling technique known as a hierarchical Bayesian model. Under this framework, we assume the vector of the transformed parameters ϕ for a particular cell follows a multivariate normal distribution that describes how these parameters are distributed between all cells, namely . Given our choice of parameter transformation, this is equivalent to writing θ ∼ LogNormal(μ, Σ), that is, the vector of parameters θ for a particular cell follows a multivariate log-normal distribution. Then, we used the hierarchical Bayesian model to infer the mean vector μ and covariance matrix Σ across cells and hence determined any correlation in model parameter sets between cells. The parameter dependency for this hierarchical Bayesian model is shown in Fig. S5.
The full hierarchical Bayesian likelihood was specified as the product of 1) the probability of producing data yj on each cell j given the parameter vector for each cell θj and noise σj; 2) the probability of obtaining each individual well parameter set θj from the “top-level” LogNormal distribution across wells defined by the hyperparameters; and 3) the priors—the prior of the hyperparameters (also known as the “hyperprior”) and the prior of σj. That is,
(7) |
where μ, Σ are the hyperparameters of the hierarchical model representing the mean vector and covariance matrix of the individual “low-level” parameters and are the set of individual “low-level” parameters for each of the Ne repeats of the experimental recordings .
We sampled the full hierarchical Bayesian model using a simplified version of the Metropolis within Gibbs (24) method, which we have termed “pseudo-Metropolis within Gibbs” (see Fig. S9; Supporting Materials and Methods, Section S6, but note this simplification is only applicable for our particular setting, in which the number of data points in the time traces vastly outweighs the number of cells). We also describe the details of the choice of likelihoods and priors and sampling algorithms in Supporting Materials and Methods, Section S6, and we test the LogNormal distribution assumption in Supporting Materials and Methods, Section S8.
We used the inferred covariance matrix Σ to study the correlation (corr(θ)) between the model parameters, which are related by
(8) |
where diag(.)−1/2 denotes the square root of the matrix of the diagonal entries. The posterior predictive distribution p(θ|...) allows us to make predictions about how future experiments will behave, where (...) indicates all other variables appearing in Eq. 7. It can be computed using
(9) |
where Θ = {μ, Σ}, a concatenation of all the individual hyperparameters within μ and Σ. The integration was approximated by summing over the probability density functions, which are defined by the samples of Θ.
Synthetic data studies
Before implementing experiments, we confirmed the identifiability of model parameters using our protocols and parameter inference algorithms through a synthetic data study. We generated synthetic data (with added synthetic noise) with some known “true” parameters θtrue. First, we used the synthetic data to design and optimize our protocols and to ensure that the protocols give access to sufficient information for parameter characterization. Second, we assessed our inference methods, described in the previous section, by asking how confident we are in our inferred parameters. In Supporting Materials and Methods, Section S6.3.1, we show that our newly designed protocol, the “staircase protocol” (see Fig. 1 C), is information-rich, in that we are able to fully recover the “true” parameter in a synthetic data study using our protocol.
We also tested our hierarchical Bayesian model to ensure that it is possible to infer the underlying distribution of the parameters. We generated our individual synthetic data from a predefined multivariate normal distribution, in which parameters are correlated. In Supporting Materials and Methods, Section S6.3.2, we applied our hierarchical Bayesian model analysis to the synthetic data, assuming we did not know the underlying covariance between parameters, and we were able to reconstruct the correlation matrix of our predefined distribution with very high accuracy. This provides us with confidence that our method is able to correctly infer the underlying correlation between parameters. We describe the rationale and procedure of the synthetic data study in detail in Supporting Materials and Methods, Section S6.
Experimental methods
Whole-cell patch-clamp voltage-clamp experiments were performed on Chinese hamster ovary (CHO) cells stably transfected with hERG1a (Kv11.1), with temperature control set to 25°C, using the Nanion SyncroPatch 384PE platform (Nanion Technologies). The temperature of the system’s “cell hotel” was set to ∼15°C. The machine is an automated high-throughput platform, in which each run (or chip) is able to measure up to 384 wells (with one cell per well) simultaneously. Single-hole chips with medium resistance (Nanion order number #221102) were used. Solutions used in all measurements are provided in Table S2.
A schematic of the experimental procedure is shown in Fig. 2, which shows the voltage-clamp protocols used in the experiments. A total of nine voltage-clamp protocols were used, including (green) our newly developed staircase protocol, (blue) an activation current-voltage (I-V) protocol, a steady-state inactivation I-V protocol, a hERG screening protocol, a delayed afterdepolarization (DAD)-like protocol, an early afterdepolarization (EAD)-like protocol, and action-potential-like protocols with beating frequency 0.5, 1, and 2 Hz, as shown in Fig. 2. Note that, because of the automated platform, the action-potential-like protocols have to be composed of a series of linear ramps and steps rather than curves. Details of the protocols are given in Supporting Materials and Methods, Section S1. Every protocol (the entire procedure in Fig. 2) was applied to every well. Because our quality control (see next section) is primarily based on the calibration recording, we decided to apply the calibration protocol at the end such that we can check the cell is stable for the entire experiment, including the validation protocols.
Only the staircase protocol (green) was used in fitting (or calibrating) the mathematical model. We show that we can fully characterize IKr for each cell using just this one protocol because our staircase protocol is information-rich. A comparison between the staircase protocol and a previously developed protocol (9) is shown in Fig. 1, B and C. However, because of hardware limitations, the previous protocol does not work in most high-throughput automated systems because they cannot perform clamps to arbitrary time-varying functions and are restricted to ramps and steps. Hence, a similar idea from Beattie et al. (9)—using an information-rich protocol—was adapted, and the rationale of our staircase protocol is discussed below. We designed the staircase protocol with only voltage steps and ramps such that it is applicable to any patch-clamp machine, including the high-throughput automated systems.
A demonstration that a mathematical model is able to reproduce the experimental training data is not sufficient to conclude that it is a good representation of ion channel kinetics—in particular, we may be uncertain how well the model performs under physiological conditions. The fitted models for each cell were therefore validated by comparison with experimental data from each of the other eight protocols (blue in Fig. 2). Our validation set consists of 1) two traditional I-V protocols together with a simple hERG activation step and 2) five physiologically inspired protocols that mimic cardiac action potentials. The first set allows us to compare with the traditional approach. More importantly, the second set allows us to have confidence in predictions of IKr responses, which is particularly useful when an ion channel model is embedded in a cardiac action potential model. This series of validations allows us to demonstrate that the models fitted using this new protocol yield trustworthy cell-specific predictions.
Protocol design
The underlying rationale of the staircase protocol shown in Fig. 2 is to force the protocol to explore the full dynamics of the system at different voltage values, over a physiologically relevant voltage range. By observing the changes in the current after each step, the voltage dependency of the channel at that particular voltage can be deduced. Each voltage step is held for 500 ms, which is chosen to be long enough to observe the characteristic decay of IKr. Therefore, by going through different step-ups and downs, the protocol explores the dynamics at different voltage values, and hence our statistical inference method is able to infer the underlying model parameters.
Two ramps are implemented before and after the main staircase. The ramp at the beginning, termed the “leak ramp,” is used to estimate the leak current; see the next section for more details. The second one, happening after 14 s and termed the “reversal ramp,” is designed to estimate experimentally the reversal potential EK by having a ramp over 100 ms that quickly crosses the expected EK, which we expect to be in the range of −70 to −100 mV. We therefore implemented a large step up to +40 mV before the ramp to open the channel so that we can record a high signal-to-noise ratio (SNR) IKr trace that goes from positive to negative before the channel closes. Examples of currents during the two ramps are shown in Fig. S2.
Postprocessing experimental data
We assumed that our observed current from hERG CHO cells under control conditions is
(10) |
To ensure the currents we analyze are predominantly IKr, we performed a series of offline postprocessing corrections. First, leak corrections were applied to all measurements to eliminate the leak current . Second, E-4031 subtraction was applied to remove Iendogenous (the sum of any native voltage-dependent ion currents that were present in CHO cells alongside the overexpressed hERG). These corrections are described in detail below, as well as our partially automated quality control criteria.
E-4031 subtraction
To eliminate any endogenous voltage-dependent background currents within the hERG CHO cells (Iendogenous in Eq. 10), we measured the full set of nine voltage protocols twice (see Fig. 2); once with dimethyl vehicle conditions, in which in Eq. 10 was measured, and once under the addition of 0.5 μM E-4031, a hERG channel selective blocker with IC50 value 10 nM, so that
(11) |
As shown in Fig. 2, a period of ∼5 min was allowed for the E-4031 block to reach equilibrium, and multiple hERG screening protocols were applied to allow opening of the hERG channel (25). We denoted the new leak current as , and we assumed leak current changed over time; hence, in general, . All currents shown or used in this study are the leak-corrected currents measured in control conditions minus the leak-corrected currents that remained after E-4031 addition, which we assume yields uncontaminated IKr.
Leak correction
We used the common assumption that leak current is linear in voltage to estimate its magnitude along the whole current trace
(12) |
where gleak is the leak current conductance and Eleak is the leak current reversal potential. If we subtract an estimated leak off both and , then our final IKr can be given by
where are leak currents estimated using Eq. 12. Depending on the protocol, we estimate the parameters gleak, Eleak in one of two ways: either by using a step between two voltages or by using a linear ramp, as discussed below.
We assumed that at −80 mV, IKr is fully closed and will not be opened by going to a voltage below −80 mV. We therefore implemented the leak ramp: a linear ramp from −120 to −80 mV over 400 ms, as seen in the first second of the staircase protocol (green) in Fig. 2. All nonzero current measured during the leak ramp was assumed to be leak current in the form of Eq. 12, and a linear regression was used to fit its I-V relation and to obtain the leak model parameters. We show in detail the use of our leak ramp to infer the leak model parameters in Fig. S2, in which we can see that the recorded current during the ramp shows a reliably good linear relation. Therefore, this leak ramp can be used to check the linearity of the leak current, that is, the linearity in its I-V relation, which cannot be achieved using the standard voltage step method for leak estimation.
In a similar fashion, for all validation protocols, instead of a linear ramp, a traditional step method was used. A 20 ms leak step from −80 to −100 mV was used to leak-correct the experimental data. This method was implemented and performed automatically by the platform we used before every protocol to correct the recording that followed. However, we noticed that some of these leak corrections can “overcorrect” or “undercorrect” the current. For example, IKr should only be negative when the voltage is below its reversal potential, approximately −85.2 mV; if the leak-corrected current showed a negative current at voltages substantially larger than the reversal potential, then we concluded that the automated system had overestimated the leak current. Such overcorrection or undercorrection was most noticeable during the highest voltage step during the protocol, at which Ileak was at its maximum. For each validation protocol, we then specified a time window during which we believe IKr should be almost zero (please refer to our GitHub repository for detail). To rectify the over- or undercorrection, we re-estimated the leak correction by adding an extra linear leak current of the form (V + 80 mV), where was chosen such that the average of the final leak-corrected current during the specified time window was zero. Because of the linearity, the final leak correction remains equivalent to Eq. 12 with different parameters.
Partially automated quality control
After the experiments, we applied a strict set of criteria as an automated selection process for quality control of our experimental data. The details of our criteria are summarized in Table 1. We applied a strict cutoff for seal resistance (Rseal), cell capacitance (Cm), and series resistance (Rseries) through the whole set of measurements, set by our first quality control criterion (QC1). QC2 required a high signal-to-noise ratio (SNR) recording, such that our measurements contained enough useful information for model inference. We also compared the stability of the recordings in QC3, in which each protocol consisted of two measurements recorded in the same cell that must be similar and stable. QC4 required Rseal, Cm, and Rseries to be stable before and after E-4031 addition. QC5 required that the addition of hERG blocker E-4031 must reduce a certain amount of the recorded current to ensure that our recordings consisted mainly of IKr even before adding the blocker. Finally, overcorrection of leak can occur during high voltage steps, as discussed in the previous section; QC6 ensured that no negative current occurred at voltages substantially larger than the reversal potential. Note that QC1 to QC4 are general criteria that are advocated to be used in all whole-cell patch-clamp voltage-clamp experiments, whereas QC5 and QC6 contain prior knowledge of IKr and are tailored to hERG measurements.
Table 1.
QC Name | Criterion Description |
---|---|
QC1.Rseal | Check Rseal within [0.1, 1000] GΩ. |
QC1.Cm | Check Cm within [1, 100] pF. |
QC1.Rseries | Check Rseries within [1, 25] MΩ. |
QC2.raw | Check raw trace recording SNR is over 25 (SNR defined as var(trace)/var(noise)). |
QC2.subtracted | Check subtracted trace SNR > 25. |
QC3.raw | Check 2 sweeps of raw trace recording are similar by comparing the RMSD of the two sweeps < mean(RMSD to zero of the two sweeps) × 0.2. |
QC3.E4031 | Check 2 sweeps of E-4031 trace recording are similar (same comparison as QC3.raw). |
QC3.subtracted | Check 2 sweeps of subtracted trace recording are similar (same comparison as QC3.raw). |
QC4… | Check Rseal, Cm, Rseries, respectively, before and after E-4031 change (defined as std/mean) < 0.5. |
QC5.staircase | Check the maximum current during the second half of the staircase changes by at least 75% of the raw trace after E-4031 addition. |
QC5.1.staircase | Check RMSD to zero of staircase protocol changes by at least 50% of the raw trace after E-4031 addition. |
QC6.subtracted | Check the first step up to40 mV, before the staircase, in the subtracted trace is bigger than −2× estimated noise level. |
QC6.1.subtracted | Check the first40 mV during the staircase, with the same criterion as QC6.subtracted. |
QC6.2.subtracted | Check the second40 mV during the staircase, with the same criterion as QC6.subtracted. |
RMSD, root mean-square difference; SNR, signal-to-noise ratio; std, standard deviation; var, variance.
Using our automated high-throughput system, we recorded a total of 384 well recordings. Our automated quality control removed 173 wells, leaving 211 well recordings. We then manually checked all the recordings and subsequently removed a further 28 wells that did not look anything like the rest of the 183 cells; six typical examples are shown in Fig. S4. Therefore, our automated quality control has achieved >86% positive predictive value. The machine’s “standard” quality control selects wells based mainly on the Rseal, Cm, and Rseries values, and it was configured to use the same values as our automated QC1 in Table 1. The machine removed only 46 of the wells (which were all within our 173 discarded wells). Further comparisons and details of our automated quality control results are shown in Supporting Materials and Methods, Section S5. Our automated quality control is available at our GitHub repository.
Our mostly automated quality control was applied only to the staircase calibration protocol. In this study, we further require our validation data to contain high-quality validation recordings. We therefore manually selected 124 cells within our 183 cells that passed our quality control and hence have good recordings for both calibration and validation protocols; this ensures the quality of the experimental data used in this study. The overall success rate of recording our staircase protocol is 183 of 384 wells and for the full set of protocols is 124 of 384 wells, which can be performed within 1 h.
Results
High-throughput experimental recordings
Fig. 3 shows the voltage-clamp recordings measured with the nine different protocols and the corresponding voltage protocols. All results shown are the first of the two repeats of our recordings. Our analysis was repeated for the second of the two repeats to ensure the reproducibility of our results in the same cells: the intrinsic (within-cell) variability is sufficiently small to appear negligible (see Fig. S12).
Fig. 3 A shows the staircase protocol (black) and the corresponding experimental recordings (blue). The middle panel shows the raw current recording of a single cell; the bottom panel shows the normalized current recordings from all 124 wells that passed quality control. Normalization is applied for visual comparison only because each hERG-transfected CHO cell is expected to have a different total conductance, hence giving a different magnitude of the current recorded. Currents are normalized by scaling them to minimize the absolute difference between each trace and a reference trace (middle panel). Because the reference trace is used only to normalize other traces for visualization, we simply picked a representative trace from our data that had reasonably low noise. Our recordings show a very similar result to the IKr simulation shown in Fig. 1, which used parameters calculated completely independently by Beattie et al. (9).
Fig. 3, B–I show the recordings of the other eight validation protocols from the same cells. The activation step in Fig. 3 D recorded a typical IKr response, in which the step-down of voltage to −40 mV largely opens the channels. Fig. 3, G–I also show typical IKr responses to the action-potential clamp at different pacing frequencies, at which IKr is active during repolarization of the action potential. Also note the sharp opening of IKr at the upstroke that changes with pacing frequencies and increases dramatically but very consistently across all the recorded cells.
Individual cell fitting and validation
Fig. 4 shows the same voltage-clamp recordings (blue) in Fig. 3, measured under the nine different protocols (black), together with model fitting and validation results. All recordings shown were performed on a single cell. The mathematical model, shown as red lines, is fitted only to the data recorded under the staircase protocol that is shown in Fig. 4 A. The result of the fitting for a single cell is shown in the middle panel of Fig. 4 A, demonstrating an excellent fit between experimental measurement and simulated current. The inferred parameters are shown and studied in detail in the next three sections.
In Fig. 4, B–I, we show the results of the validation predictions under eight other protocols. We validated our trained model by testing its ability to predict independent experimental outcomes under different protocols, which were measured in the same cell. All validation predictions were performed by using the inferred parameters in the fit to the staircase protocol (Fig. 4 A) to simulate the other eight protocols (Fig. 4, B–I). The predictions of all the protocols match very well to the experimental data, with the simulated currents giving a close match to the experimental recordings.
The physiologically inspired voltage-clamp protocols (Fig. 4, E–I) mimic the membrane voltage of the cardiac action potential at normal conditions at different beating rate and EAD/DAD-like conditions. The ability to predict the current response under these physiologically inspired voltage-clamp protocols is particularly important for use in physiological or pharmacological studies. This shows the reliability of the hERG ion channel model predictions at different physiological conditions, for example, when it is embedded in a whole-cell cardiac model for further predictions.
In Fig. 5, we present our model fitting and validation results for all 124 cells, compared against the experimental recordings measured under the nine different protocols. We applied the same fitting and validation procedure as used for the single cell discussed above to all 124 cell measurements. To visualize the variability in only hERG kinetics (and not maximum conductance), we plotted all currents normalized as described in the previous section.
We quantified the fits and predictions using relative root mean-square error (RRMSE), defined as the root mean-square error between the model simulation and the experimental data, divided by the root mean-square distance of the data to a zero-current trace:
(14) |
Using this RRMSE quantification, the difference in the absolute size of the current across cells due to varying conductance is eliminated, and RRMSE scores are comparable between cells. Fig. 6 shows the RRMSE histograms for all cells and for six of the protocols. Markers indicate the best (∗), median (‡), and 90th percentile (#) RRMSE values, and corresponding raw traces are shown in the three panels above. The solid diamond marker (◆) indicates the reference cell shown in Figs. 3 and 4. The same analysis applied to the remaining three protocols is shown in Fig. S15. There are some small discrepancies in the predictions, for example, in Fig. 6 B in the 90th percentile predictions. But overall, these results demonstrate that all our 124 models make very good predictions for the recorded current kinetics.
Next, we first qualitatively inspect the variability in the hERG kinetics measurements. Because we measured the IKr using exactly the same experimental setup for each cell, we can clearly see the variability between measurements in all of the recordings, as illustrated in Fig. 5. Different protocols demonstrate different levels of variation. It is clear that among the six protocols, the staircase protocol and the two I-V protocols show the strongest variation between measurements.
To investigate this further, we have used our mathematical model to study the variability in the parameter values that could drive the observed variability in the outputs. Fig. 7 shows the inferred parameter values which are used in the model predictions in Fig. 5. Because we assume all cells share the same mechanistic model underlying the hERG currents our inferred cell-specific model parameters capture the cell-to-cell variability, or rather, experiment-to-experiment variability. In Fig. 7, our inferred parameters are plotted against manual patch parameters (shown as orange dots/red squares), measured at a slightly lower (room) temperature, from Beattie et al. (9); our identified parameters are broadly in alignment with manual patch results. This agreement gives us further confidence that our high-throughput method is reproducible and biophysically meaningful. We can also see that there is more variability in some parameters than others, also seen in the previous study (9). In particular, p1, p3, and p6 show stronger variability that varies over an order of magnitude, whereas the others vary only within an order of magnitude. Conductance gKr also varies significantly, but this might be expected given different sizes and expression levels for individual cells.
A hierarchical Bayesian modeling approach to characterize well-to-well variability
We applied the hierarchical Bayesian model to analyze the variability within the experimental recordings and correlations between inferred well-to-well parameter sets. The result of applying our hierarchical model is shown in Fig. 8. The measurement uncertainty for the parameters of each individual well is shown with a marginal posterior distribution, the colored histograms. Most of the parameters give a narrow credible interval, which reinforces our certainty in the information content of the calibration protocol. Many of the marginal posterior distributions of the individual wells overlap, that is, we cannot distinguish between the two sets of parameters given our uncertainty in them. However, some of the individual marginal posterior distributions are distinct from each other, demonstrating considerable variability between wells.
The power of the hierarchical Bayesian model can then be used to summarize and capture the experiment-to-experiment variability. The hyperparameters of the model describe both the mean μ and (co)variance Σ of parameter sets across wells, with experimental uncertainty taken into account. We estimated this posterior predictive distribution (Eq. 9) from the samples of hyperparameters, and its marginal distributions are shown for each parameter as the red curves in Fig. 8. This distribution can be used to predict the likelihood and variability of parameter sets from further wells in future experiments. The mean values of the samples of μ (which is equivalent to the mean of the posterior predictive distribution) and its 95% credible intervals are provided in Table S3. To compare with previous literature values, we plotted the activation and inactivation steady-state curves a∞ and r∞ from these parameter sets alongside results from Sanguinetti et al. (1), resulting in a good correspondence shown in Fig. S18.
Finally, we utilized the hierarchical Bayesian model to investigate the correlation between model parameters across different wells. In the sampled hyperparameters, the covariance matrix Σ reveals any correlation between our model parameters. The typical assumption concerning the variability of parameters is that parameters are independent, i.e., in the covariance matrix, all entries except the diagonal are zero. In the upper triangle (orange) of Fig. 9, we compare our inferred correlation between parameters (calculated using Eq. 8) with this common assumption (black vertical dashed lines). It is obvious that there are many entries in which zero is outside our credible interval, which is equivalent to showing that the independence assumption is not supported by our findings.
To visualize the correlation between parameters better, the 95% credible regions for each pair of parameters are shown in the lower triangle (blue) of Fig. 9, plotted against the scatter plot of the 124 cells’ individual posterior mean parameters (shown on a log-scale). Each blue ellipse is reconstructed from a sample of hyperparameters, where the contour of the 95% credible region of the two-variate marginal distribution defined by the hyperparameter sample is shown, capturing most of our individual posterior mean parameters appropriately. In this plot, a perfect circle implies there is no correlation between the pair of parameters. However, we can clearly see that most of our pairwise parameters show an elliptical shape, which means some degree of correlation between the pairwise parameters exists. This strongly suggests that correlations between parameters are embedded in the experiment-to-experiment variability. To ensure our observed correlations are biophysically relevant rather than a sign of identifiability problems, in Supporting Materials and Methods, Section S10, two figures show how cell-specific parameters make accurate cell-specific predictions. We further discuss explanations for such observed correlations in the Discussion.
Discussion
In this study, we have developed a short, high-information-content staircase voltage-clamp protocol for IKr that is applicable in automated high-throughput patch-clamp systems and used a mathematical model to characterize channel kinetics by fitting its parameters to recordings made under this new protocol. This study will advance future ion channel model development and model selection and forms a basis for improved screening of ion channel kinetics under different conditions, mutations, or pharmaceutical compounds.
Here, we no longer use I-V or τ-V relations to characterize hERG kinetics, but rather, we use a mechanistic model and its parameterization to capture our knowledge of channel kinetics. An optimized voltage protocol, which is short and has a high information content, was used to parameterize the hERG kinetics model. The benefits of this approach are threefold. First, current “rundown” during the protocol has less of an effect over shorter experiments (tens of seconds) as compared to traditional I-V and τ-V protocols (tens of minutes); hence, it is much easier to obtain a measurement that remains stable. Second, given its short duration, it is easy to repeat the measurement to examine within-cell reproducibility and/or variability. Third, our staircase protocol can be used to rapidly create cell-specific models of kinetics (which is much harder to do using the more time-consuming traditional I-V and τ-V protocols).
We have shown that our 15 s staircase protocol can be performed in an automated high-throughput system. We have found that each of the resulting 124 models is consistent with previous manual patch-clamp results (limited to nine cells) (9), implying that these methods are reproducible. We can now easily produce large data sets for further analysis, which is usually difficult, if not impossible, to achieve with manual patch clamp. The predictions of the cell-specific models are not perfect, as we examined in Fig. 6, and there may be room for improvement in terms of the model structure and further optimization of the calibration protocol. But we are able to calibrate our model to the extent that it can replicate both experimental training data and predict validation data very well (Fig. 4). Our models can predict the current response to the physiologically relevant action potential protocols, demonstrating that our IKr models could be useful in predicting cardiac electrical activity in both healthy and arrhythmic situations (9). This provides assurance that our cell-specific models, which are constructed in a high-throughput manner, have great potential for future uses.
For example, our method can potentially be adapted and used to investigate not only how much the hERG channel is blocked by a drug but also how that drug influences channel kinetics. This might be useful for the Comprehensive in vitro Proarrhythmia Assay initiative because both automated high-throughput systems and in silico modeling constitute the core of the initiative (26, 27). Our approach may give us a better understanding of the pharmacological properties of drugs in the screening process and hence a better pharmaceutical safety assessment. We can also incorporate the cell-to-cell or experiment-to-experiment variability in the in silico modeling as part of the uncertainty quantification for safety-critical predictions (15). Furthermore, such rapid characterization using high-throughput systems can benefit precision and personalized medicine. For example, when using human-induced pluripotent stem cell-derived cardiomyocytes, as described in Lei et al. (28), characterization of ion current kinetics may need to be taken into account to tailor accurate cell-line-specific models.
With our 124 cell-specific hERG models, we are able to study experiment-to-experiment variability in the hERG channel. Such experiment-to-experiment variability is captured using our hierarchical Bayesian model, in which the posterior predictive distribution is constructed and describes the underlying variability of the parameters (Fig. 8). Instead of using a series of I-V and time constant-voltage curves, here, we evaluate the variability of the observed hERG channel kinetics using mathematical model parameters. The variability in the parameter values predicts the observed differences in the channel kinetics; see also Supporting Materials and Methods, Section S10. In addition, we can use our posterior predictive distribution to predict what might happen in future experiments based on the observed experiments.
Sources of variability
We have successfully quantified the variability between wells via our inferred model parameters. However, the underlying cause of this variability is an open question. There are possibilities at two extremes. One is that the variability is truly cell-to-cell and ion channel kinetics do vary because of different intracellular conditions, which one may speculate is due to differing gene expression, subunits, phosphorylation states, or suchlike. The other possibility is that ion channel kinetics are precisely identical in each cell but there are some experimental artifacts, varying between wells, that are causing the observed variability in parameters from each well. Below, we discuss hints in our results as to which of these extremes is the leading cause of variability.
As mentioned in the rationale of the staircase protocol, the 100 ms reversal ramp at 14.41 s was introduced to estimate experimentally the hERG reversal potential in each of the j wells; for details, see Fig. S2. Fig. 10 shows an example derivation using the reversal ramp and a histogram of values estimated from the 124 wells.
Our obtained histogram of values is distributed close to our theoretical EK from the Nernst equation (Eq. 2), with an SD of 1.36 mV. Because all of our measurements were performed on one 384-well plate, they shared the same extra- and intracellular solutions and were recorded at (almost) the same temperature. We would therefore expect the real variability in reversal potential to be much smaller than this observed variability.
A hypothesis then, is that reversal potential EK really occurs at the Nernst calculated value, and observed deviations from this inferred from the reversal ramp provide an estimate for a “voltage error” in the applied voltage clamp: , perhaps due to an imperfect compensations of other external effects, such as junction potentials and electrode offsets. We can investigate this hypothesis via the model by applying a staircase protocol with voltage error offsets of ΔVj estimated from each of the 124 cells, generating synthetic data from these voltage clamps, and then refitting parameters.
Fig. 9 (lower triangle) shows the results of our voltage error offset simulations in red dots. If there was an error in the applied voltage clamp in each well, then we would expect to see parameters appearing to covary along the red lines (made up of individual dots/fits) in Fig. 9. The observed primary parameter covariance directions and magnitudes from this procedure (red lines) align suspiciously well with much of the observed variability in the experiments (blue ellipses inferred from gray dots). In Supporting Materials and Methods, Section S13, we extend Fig. 9 (lower triangle) to show the value of ΔVj for each individual well j, which indeed finds a correlation along the proposed directions, further supporting the hypothesis.
This is strong circumstantial evidence—a smoking gun—suggesting that the majority of the observed variability in parameters may be due to well-well variability in patch-clamp artifacts rather than cell-cell variability in ion channel kinetics. We explored the possibility of the quality control parameters having direct bearing on the estimated voltage error; however, no obvious correlation between these values is apparent, as shown in Fig. S19. Building a more complete mathematical model of such patch-clamp artifacts is part of our future plans. We should also note that despite patch-clamp artifacts being an apparent cause of parameter variability, they are not necessarily larger artifacts in this automated system than might be expected in manual patch clamp.
Finally, if we were to believe that the observed variability here arises from experimental artifacts, then only the uncertainty in the top-level mean parameter vector μ in the hierarchical Bayesian model is representative of our uncertainty in the underlying physiology. That is, the variability of top-level mean parameter vector μ should be included in future physiological studies, for example, in the second part of this study (this issue of Biophysical Journal, Lei et al. (29)) or when embedding an ion channel model within an action potential model, whereas the full posterior predictive distribution should be used only when predicting the results of future patch-clamp experiments.
Conclusions
In this study, we have demonstrated the feasibility and practicality of using a 15 second staircase protocol to study and characterize hERG channel kinetics on an automated high-throughput system. We calibrated the hERG model to our staircase protocol for 124 hERG cells. Our 124 cell-specific variants of the hERG model are able to predict eight other protocols with a high accuracy, including physiologically inspired action-potential-like voltage clamps. Using a hierarchical Bayesian modeling approach, we provide a quantitative description of the variability and uncertainty within our 124 cell-specific models.
With our rapid characterization techniques and the hierarchical Bayesian modeling approach, we have opened a, to our knowledge, new gateway to study parameter correlations between cells and investigate experimental variability. We have found that some model parameters are strongly cross-correlated, but not all. This result may hint at the origin of the variability and requires further investigation. In future, we aim to design protocols to allow high-throughput systems to be used to investigate not only how much the hERG channel is blocked by a drug but also the kinetics of drug binding and whether the drug influences underlying channel kinetics.
All codes and data are freely available at https://github.com/CardiacModelling/hERGRapidCharacterisation, a permanently archived version is available on Figshare at https://doi.org/10.1016/j.bpj.2019.07.030.
Author Contributions
C.L.L., M.C., D.J.G., L.P., G.R.M., and K.W. designed the research. C.L.L., L.P., and K.W. carried out the experiments. C.L.L., M.C., D.J.G., and G.R.M. designed the computational analysis. C.L.L. wrote simulation codes, performed the analysis, and generated the results figures. All authors wrote and approved the final version of the manuscript.
Acknowledgments
We thank Nanion for assistance with automating the export of current trace data.
This work was supported by the Wellcome Trust (grant numbers 101222/Z/13/Z and 212203/Z/18/Z), the Engineering and Physical Sciences Research Council and the Medical Research Council (grant number EP/L016044/1), and the Biotechnology and Biological Sciences Research Council (grant number BB/P010008/1). C.L.L. acknowledges support from the Clarendon Scholarship Fund; and the Engineering and Physical Sciences Research Council, Medical Research Council, and F. Hoffman-LaRoche Ltd for studentship support via the Oxford Systems Approaches to Biomedical Science Centre for Doctoral Training. M.C. and D.J.G. acknowledge support from a Biotechnology and Biological Sciences Research Council project grant. G.R.M. acknowledges support from the Wellcome Trust and Royal Society via a Sir Henry Dale Fellowship and a Wellcome Trust Senior Research Fellowship. L.P. and K.W. are employees of F. Hoffman-LaRoche Ltd., and K.W. is a shareholder.
Editor: Zhilin Qu.
Footnotes
Supporting Material can be found online at https://doi.org/10.1016/j.bpj.2019.07.029.
Supporting Material
References
- 1.Sanguinetti M.C., Jiang C., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307. doi: 10.1016/0092-8674(95)90340-2. [DOI] [PubMed] [Google Scholar]
- 2.Jurkiewicz N.K., Sanguinetti M.C. Rate-dependent prolongation of cardiac action potentials by a methanesulfonanilide class III antiarrhythmic agent. Specific block of rapidly activating delayed rectifier K+ current by dofetilide. Circ. Res. 1993;72:75–83. doi: 10.1161/01.res.72.1.75. [DOI] [PubMed] [Google Scholar]
- 3.Malik M., Camm A.J. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labelling. Drug Saf. 2001;24:323–351. doi: 10.2165/00002018-200124050-00001. [DOI] [PubMed] [Google Scholar]
- 4.Friedrichs G.S., Patmore L., Bass A. Non-clinical evaluation of ventricular repolarization (ICH S7B): results of an interim survey of international pharmaceutical companies. J. Pharmacol. Toxicol. Methods. 2005;52:6–11. doi: 10.1016/j.vascn.2005.05.001. [DOI] [PubMed] [Google Scholar]
- 5.Mirams G.R., Cui Y., Noble D. Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk. Cardiovasc. Res. 2011;91:53–61. doi: 10.1093/cvr/cvr044. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Li Z., Ridder B.J., Strauss D.G. Assessment of an in silico mechanistic model for proarrhythmia risk prediction under the CiPA initiative. Clin. Pharmacol. Ther. 2019;105:466–475. doi: 10.1002/cpt.1184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Vanoye C.G., Desai R.R., George A.L., Jr. High-throughput functional evaluation of KCNQ1 decrypts variants of unknown significance. Circ Genom Precis Med. 2018;11:e002345. doi: 10.1161/CIRCGEN.118.002345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Pathmanathan P., Shotwell M.S., Gray R.A. Uncertainty quantification of fast sodium current steady-state inactivation for multi-scale models of cardiac electrophysiology. Prog. Biophys. Mol. Biol. 2015;117:4–18. doi: 10.1016/j.pbiomolbio.2015.01.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Beattie K.A., Hill A.P., Mirams G.R. Sinusoidal voltage protocols for rapid characterisation of ion channel kinetics. J. Physiol. 2018;596:1813–1828. doi: 10.1113/JP275733. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Hodgkin A.L., Huxley A.F. A quantitative description of membrane current and its application to conduction and excitation in nerve. J. Physiol. 1952;117:500–544. doi: 10.1113/jphysiol.1952.sp004764. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Vandenberg J.I., Varghese A., Huang C.L. Temperature dependence of human ether-a-go-go-related gene K+ currents. Am. J. Physiol. Cell Physiol. 2006;291:C165–C175. doi: 10.1152/ajpcell.00596.2005. [DOI] [PubMed] [Google Scholar]
- 12.Hobbs K.H., Hooper S.L. Using complicated, wide dynamic range driving to develop models of single neurons in single recording sessions. J. Neurophysiol. 2008;99:1871–1883. doi: 10.1152/jn.00032.2008. [DOI] [PubMed] [Google Scholar]
- 13.Fink M., Noble D. Markov models for ion channels: versatility versus identifiability and speed. Philos. Trans. A Math. Phys. Eng. Sci. 2009;367:2161–2179. doi: 10.1098/rsta.2008.0301. [DOI] [PubMed] [Google Scholar]
- 14.Kirsch G.E., Trepakova E.S., Brown A.M. Variability in the measurement of hERG potassium channel inhibition: effects of temperature and stimulus pattern. J. Pharmacol. Toxicol. Methods. 2004;50:93–101. doi: 10.1016/j.vascn.2004.06.003. [DOI] [PubMed] [Google Scholar]
- 15.Mirams G.R., Pathmanathan P., Clayton R.H. Uncertainty and variability in computational and mathematical models of cardiac physiology. J. Physiol. 2016;594:6833–6847. doi: 10.1113/JP271671. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Zeng J., Laurita K.R., Rudy Y. Two components of the delayed rectifier K+ current in ventricular myocytes of the Guinea pig type. Theoretical formulation and their role in repolarization. Circ. Res. 1995;77:140–152. doi: 10.1161/01.res.77.1.140. [DOI] [PubMed] [Google Scholar]
- 17.ten Tusscher K.H., Noble D., Panfilov A.V. A model for human ventricular tissue. Am. J. Physiol. Heart Circ. Physiol. 2004;286:H1573–H1589. doi: 10.1152/ajpheart.00794.2003. [DOI] [PubMed] [Google Scholar]
- 18.Clerx M., Collins P., Volders P.G. Myokit: a simple interface to cardiac cellular electrophysiology. Prog. Biophys. Mol. Biol. 2016;120:100–114. doi: 10.1016/j.pbiomolbio.2015.12.008. [DOI] [PubMed] [Google Scholar]
- 19.Hindmarsh A.C., Brown P.N., Woodward C.S. SUNDIALS: suite of nonlinear and differential/algebraic equation solvers. ACM Trans. Math. Softw. 2005;31:363–396. [Google Scholar]
- 20.Hansen N. The CMA Evolution Strategy: A Comparing Review. In: Lozano J.A., Larrañaga P., Inza I., editors. Toward a New Evolutionary Computation. Springer; 2006. pp. 75–102. [Google Scholar]
- 21.Jasra A., Stephens D.A., Holmes C.C. On population-based simulation for static inference. Stat. Comput. 2007;17:263–279. [Google Scholar]
- 22.Haario H., Saksman E., Tamminen J. An adaptive Metropolis algorithm. Bernoulli. 2001;7:223–242. [Google Scholar]
- 23.Clerx M., Robinson M., Gavaghan D.J. Probabilistic inference on noisy time series (PINTS) Journal of Open Research Software. 2019;7:23. [Google Scholar]
- 24.Gilks W.R., Best N., Tan K. Adaptive rejection Metropolis sampling within Gibbs sampling. Appl. Stat. 1995;44:455–472. [Google Scholar]
- 25.Ishii K., Nagai M., Endoh M. Dissociation of E-4031 from the HERG channel caused by mutations of an amino acid results in greater block at high stimulation frequency. Cardiovasc. Res. 2003;57:651–659. doi: 10.1016/s0008-6363(02)00774-5. [DOI] [PubMed] [Google Scholar]
- 26.Fermini B., Hancox J.C., Vandenberg J.I. A new perspective in the field of cardiac safety testing through the comprehensive in vitro proarrhythmia assay paradigm. J. Biomol. Screen. 2016;21:1–11. doi: 10.1177/1087057115594589. [DOI] [PubMed] [Google Scholar]
- 27.Chang K.C., Dutta S., Li Z. Uncertainty quantification reveals the importance of data variability and experimental design considerations for in silico proarrhythmia risk assessment. Front. Physiol. 2017;8:917. doi: 10.3389/fphys.2017.00917. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Lei C.L., Wang K., Polonchuk L. Tailoring mathematical models to stem-cell derived cardiomyocyte lines can improve predictions of drug-induced changes to their electrophysiology. Front. Physiol. 2017;8:986. doi: 10.3389/fphys.2017.00986. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Lei C.L., Clerx M., Mirams G.R. Rapid characterisation of hERG potassium channel kinetics II: temperature dependence. Biophys. J. 2019 doi: 10.1016/j.bpj.2019.07.030. 117:XXX. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.